Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The yeast cell cycle: positive and negative controls

M Aldea1, C Casas, C Gallego

  • 1Departament de Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida.

Microbiologia (Madrid, Spain)
|March 1, 1994
PubMed
Summary

Yeast cell cycle control at START relies on G1 cyclins activating Cdc28 kinase. A newly identified gene links nutrient availability to G1 cyclin expression, impacting cell cycle progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-based differences in tolerability of developmental antibody-drug conjugates (ADCs) in non-small-cell lung cancer (NSCLC).

ESMO open·2026
Same author

Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

MTAP loss is frequent in oncogene-driven NSCLC and may confer sensitivity to combined PRMT5 inhibitors and targeted therapies.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Next-generation multicenter studies: using artificial intelligence to automatically process unstructured health records of patients with lung cancer across multiple institutions.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

ESMO basic requirements for AI-based biomarkers in oncology (EBAI).

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50.

ESMO open·2025

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Yeast Genetics

Background:

  • Cell cycle progression in Saccharomyces cerevisiae is primarily regulated at the START transition in G1 phase.
  • Yeast cells assess environmental cues like nutrients and pheromones at START before committing to division.
  • G1 cyclins are crucial regulators, activating the Cdc28 (p34) protein kinase to control entry into the cell cycle.

Purpose of the Study:

  • To review the molecular mechanisms governing the START cell cycle point in yeast.
  • To elucidate the positive and negative regulatory factors influencing START.
  • To introduce a novel gene connecting nutrient availability to G1 cyclin expression.

Main Methods:

  • Review of existing literature on yeast cell cycle control.

Related Experiment Videos

  • Analysis of molecular pathways involving G1 cyclins and Cdc28 kinase.
  • Description of a newly identified gene and its potential role in nutrient sensing.
  • Main Results:

    • START regulation involves the precise accumulation and degradation of G1 cyclins, leading to a peak in Cdc28 kinase activity.
    • This kinase activity phosphorylates specific substrates, facilitating passage through START.
    • A novel gene has been identified that links nutrient availability to the expression of G1 cyclins.

    Conclusions:

    • The START transition is a critical checkpoint controlled by cyclin-dependent kinases and regulated by environmental signals.
    • The newly discovered gene provides a molecular link between nutrient status and cell cycle progression via G1 cyclin regulation.
    • Further investigation into the Ras-cAMP pathway may reveal additional connections to nutrient-mediated cell cycle control.